Fengping Li, Chao Ma, Cheng-shi Xu, Zhi-yong Pan, Zhiqiang Li
{"title":"胶质瘤临床治疗研究进展综述","authors":"Fengping Li, Chao Ma, Cheng-shi Xu, Zhi-yong Pan, Zhiqiang Li","doi":"10.4103/glioma.glioma_18_20","DOIUrl":null,"url":null,"abstract":"As theories evolve, the mechanism of glioma origination remains poorly understood. Understanding this mechanism promotes the clinical research on glioma therapeutic strategy and then improves the prognosis of patients with glioma. However, the overall survival of these patients is unsatisfactory. In the recent decade, a few novel therapies, such as tumor-treating fields and immunotherapy, have been introduced in clinic. Before they can be widely used, many key factors, including efficacy, safety, and benefit ratio, should be fully evaluated. Therefore, more clinical trials are required to corroborate the results and conclusions of basic research and improve the current treatment strategies. In this article, we searched relevant literature published in the past 5 years in PubMed and China National Knowledge Infrastructure and reviewed the advancements of clinical therapeutic research on glioma.","PeriodicalId":12731,"journal":{"name":"Glioma","volume":"3 1","pages":"119 - 125"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Advancement of clinical therapeutic research on glioma: A narrative review\",\"authors\":\"Fengping Li, Chao Ma, Cheng-shi Xu, Zhi-yong Pan, Zhiqiang Li\",\"doi\":\"10.4103/glioma.glioma_18_20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"As theories evolve, the mechanism of glioma origination remains poorly understood. Understanding this mechanism promotes the clinical research on glioma therapeutic strategy and then improves the prognosis of patients with glioma. However, the overall survival of these patients is unsatisfactory. In the recent decade, a few novel therapies, such as tumor-treating fields and immunotherapy, have been introduced in clinic. Before they can be widely used, many key factors, including efficacy, safety, and benefit ratio, should be fully evaluated. Therefore, more clinical trials are required to corroborate the results and conclusions of basic research and improve the current treatment strategies. In this article, we searched relevant literature published in the past 5 years in PubMed and China National Knowledge Infrastructure and reviewed the advancements of clinical therapeutic research on glioma.\",\"PeriodicalId\":12731,\"journal\":{\"name\":\"Glioma\",\"volume\":\"3 1\",\"pages\":\"119 - 125\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Glioma\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/glioma.glioma_18_20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Glioma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/glioma.glioma_18_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
随着理论的发展,神经胶质瘤起源的机制仍知之甚少。了解这一机制有助于神经胶质瘤治疗策略的临床研究,进而改善神经胶质瘤患者的预后。然而,这些患者的总体生存率并不令人满意。近十年来,一些新的治疗方法,如肿瘤治疗领域和免疫疗法,已被引入临床。在它们被广泛使用之前,应该充分评估许多关键因素,包括疗效、安全性和获益率。因此,需要更多的临床试验来证实基础研究的结果和结论,并改进当前的治疗策略。在这篇文章中,我们检索了PubMed和China National Knowledge Infrastructure在过去5年中发表的相关文献,并回顾了神经胶质瘤临床治疗研究的进展。
Advancement of clinical therapeutic research on glioma: A narrative review
As theories evolve, the mechanism of glioma origination remains poorly understood. Understanding this mechanism promotes the clinical research on glioma therapeutic strategy and then improves the prognosis of patients with glioma. However, the overall survival of these patients is unsatisfactory. In the recent decade, a few novel therapies, such as tumor-treating fields and immunotherapy, have been introduced in clinic. Before they can be widely used, many key factors, including efficacy, safety, and benefit ratio, should be fully evaluated. Therefore, more clinical trials are required to corroborate the results and conclusions of basic research and improve the current treatment strategies. In this article, we searched relevant literature published in the past 5 years in PubMed and China National Knowledge Infrastructure and reviewed the advancements of clinical therapeutic research on glioma.